Traditionally, the first-line treatment for A-fib is medication, such as beta-blockers orantiarrhythmic drugs. The next step is catheter-based ablation, a nonsurgical procedure. The process delivers radiofrequency energy into the heart to destroy tissue that’s triggering irregular rhythms. Catheter ablation has a 60 to 80 percent success rate in patients without heart abnormalities who have had A-fib for less than two years. Success rates drop if a patient has had A-fib continuously for more than two years. That option is the hybrid surgical/catheter ablation technique now offered at Porter Adventist Hospital.
For more information, contact us.
Phone: 1-855-85-HEART (854-3278)
What is it?
Hybrid ablation involves two procedures separated by six to 12 weeks. First, a cardiothoracic surgeon performs ablation on the outside of the heart with a minimally invasive surgical procedure called a thoracoscopic maze. Then, about 12 weeks later, an electrophysiologist performs catheter ablation inside the heart.
Who is it for?
Ideal candidates for hybrid ablation are patients who:
- Have heart damage resulting from A-fib lasting longer than two years
- Have failed catheter ablation
What are the advantages?
Hybrid ablation treats A-fib from both the outside and the inside of the heart muscle. The modified maze surgery is performed through keyhole incisions made between the ribs on both sides, resulting in less blood loss, shorter recovery time, and lower risk of infection than the traditional, open-heart maze surgery.
The electrophysiology lab at Porter Adventist Hospital provides cardiologists and other heart specialists with precise information about heart rhythm problems through a variety of minimally invasive treatments and tests.
Porter Adventist Hospital electrophysiology lab can identify and treat irregular heart rhythms with:
- Implantable cardioverter-defibrillator (ICD)
- Cardiac ablation procedure
WATCHMAN Left Atrial Appendage Device
The WATCHMAN Device is a unique technology to the Rocky Mountain Region, used to reduce the risk of blood clots in the left atrial appendage of atrial fibrillation (Afib) patients. Most Afib patients are at high risk for strokes caused by these blood clots.
The WATCHMAN Device treats this by being permanently implanted in the left atrial appendage of the heart, to prevent blood clots from entering the bloodstream. The procedure is done by placing a delivery catheter, through a vein in the leg that reaches the heart. The physician then pushes the WATCHMAN Device through the delivery catheter where it opens up and is permanently implanted in left atrial appendage.
Porter Adventist Hospital is one of only 100 hospitals in the nation currently offering this technology to patients.
To find out if you are a candidate or for more information contact us.
Toll-free: 1-855-85-HEART (854-3278).
Catheter ablation of atrial fibrillation, has traditionally been done utilizing fluoroscopy technology to direct catheter placement. Fluoroscopy is a type of medical imaging that poses radiation risks and exposure to the patient and electrophysiology (EP) lab staff, especially when used for an extensive period of time.
At Porter Adventist Hospital, our team performs cardiac ablations well under the national average for fluoroscopy/x-ray time. In fact, we’re the first hospital in Colorado to perform some of our Afib ablations without utilizing fluoroscopies at all.
To find more or to schedule a cardiac ablation, contact us.
Toll-free: 1-855-85-HEART (854-3278)
Catheter ablation of atypical atrial flutter: a novel 3D anatomic mapping approach to quickly localize and terminate atypical atrial flutter
Sri Sundaram1 & William Choe1 & J. Ryan Jordan1 & Nate Mullins2 & Charles Boorman2 & Eric J. Kessler3 & Sunil Nath4
Atypical atrial flutter is a rhythm that can occur after a prior ablation or after an open heart surgery procedure. It is extremely difficult to treat with medical therapy and catheter ablation. In fact, the average time in other centers is 5.1 hours. Through the work done primarily at Porter Hospital, we have found a new catheter based ablation method that can successfully treat 90% of these difficult to treat rhythms and do it in 71 minutes. We have a higher success rate and shorter procedure time than other hospitals in treating these arrhythmias.
A novel 3D anatomic mapping approach using multipoint high-density voltage gradient mapping to quickly localize and terminate typical atrial flutter
William C. Choe1 & Sri Sundaram1 & J. Ryan Jordan1 & Nate Mullins2 & Charles Boorman2 & Austin Davies2 & Alex C. Tiftickjian3 & Sunil Nath4
Typical atrial flutter is one of the most common abnormal heart rhythm problems in the US. The procedure is highly successful but can last several hours and require extensive evaluation. Through the work done primarily at Porter hospital, we have shown that similar success can be achieved by targeting the specific part of the heart responsible for this arrhythmia. We can achieve the same high rate of success but with shorter procedure times.